NVAX 是一只风险较高的生物科技股，经常遭受重创，可能再次大幅下跌，因此不应作为大仓位；它目前表现良好，说话者持有少量多头仓位，并希望加仓。
逐段跳播
嗯，我今天买了一些NVAX。你知道，这是一只风险相当高的生物科技股。它两周前因为俄罗斯那则关于埃博拉之类的新闻而冒了出来，那边到底发生了什么，我完全不知道。嗯，是什么来着？鼠疫。
哦，鼠疫。对。肺鼠疫。它又回来了，Brian。它又回来了。那么，这是这只股票的周线图。你知道，这是一家风险不小的小型生物科技公司。它经常遭受重创。所以你不应该在这上面投入太多，因为这是大多数人在看这只股票时不会注意到的，而它明天很可能又会重蹈覆辙。
但目前它的表现不错。所以我在这个股票上有一个小仓位，我的止损位大概率会设在当天最低价下方。希望我能加仓。
Um, and I bought some NVAX today. This is, you know, a fairly risky biotech stock. It surfaced two weeks ago because of that Russian news about Ebola or whatever was going on there.
I have no idea. Um, what was it ? The plague. Oh, the plague. That's right. Pneumonic plague . It's back, Brian. It is back. So, here is the weekly chart of this stock. And you know, it's a risky little biotech company.
It regularly takes heavy blows. So you shouldn't invest too much in it, because this is what most people don't pay attention to when looking at the stock, and it could easily go the same way again tomorrow.
But at the moment, it is behaving well. So I have a small position in this stock, and my stop loss will probably be below the lowest price of the day . Hopefully, I can increase that.